Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [OncoScan_CNV]

ABSTRACT: MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [OncoScan_CNV]

PROVIDER: PRJNA1063298 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology.

Project description:MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology.

| PRJNA1063355 | ENA

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [CYTOSCAN]

Project description:MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [CYTOSCAN]

| PRJNA1063297 | ENA

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology.

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-10-15 | GSE252974 | GEO

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [OncoScan_CNV]

Project description:Overall, the genetic profile of aggressive B-cell NHL in CAYA in the spectrum of BL and DLBCL is heterogeneous. MYC-R cases mostly displayed a molecular profile close to BL regardless of their morphology, whereas MYC-non-R had a more heterogeneous genetic landscape resembling DLBCL.

2024-10-15 | GSE252948 | GEO

MYC-rearranged aggressive B-cell lymphoma are molecularly Burkitt Lymphoma despite of morphology [CYTOSCAN]

2024-10-15 | GSE252947 | GEO

Expression data from Burkitt lymphoma cases

Project description:Burkitt lymphoma is the commonest cancer in children in Africa. We compared the gene expression profiles of African Burkitt lymphoma patients with those of cases presented in Western countries in both immunocompetent (sporadic Burkitt lymphoma) and HIV-infected patients (immunodeficiency associated Burkitt lymphoma). We used microarrays to detail the global programme of gene expression in different subtypes of Burkitt lymphoma.

2011-01-20 | GSE26673 | GEO

Transcription profiling of Burkitt lymphoma cases

2011-01-20 | E-GEOD-26673 | biostudies-arrayexpress

Expression Data from Burkitt Lymphoma Patients

Project description:Burkitt Lymphoma patient samples using gene expression to create a molecular definition of the disease. We used microarrays to detail the global programme of gene expression underlying cellularisation and identified distinct classes of up-regulated genes during this process. Keywords: clinical history design Samples were obtained from patients with Burkitt lymphoma and gene expression profiling was used to create a molecular definition of the disease. The molecular definition was then used to predict the disease in an independent set of patients with atypical Burkitt lymphoma and diffuse large B cell lymphoma.

2006-07-04 | E-GEOD-4732 | biostudies-arrayexpress

The genetic landscape of mutations in Burkitt lymphoma

Project description:Burkitt lymphoma is characterized by deregulation of MYC, but the contribution of other genetic mutations to the disease is largely unknown. Here, we describe the first completely sequenced genome from a Burkitt lymphoma tumor and germline DNA from the same affected individual. We further sequenced the exomes of 59 Burkitt lymphoma tumors and compared them to sequenced exomes from 94 diffuse large B-cell lymphoma (DLBCL) tumors. We identified 70 genes that were recurrently mutated in Burkitt lymphomas, including ID3, GNA13, RET, PIK3R1 and the SWI/SNF genes ARID1A and SMARCA4. Our data implicate a number of genes in cancer for the first time, including CCT6B, SALL3, FTCD and PC. ID3 mutations occurred in 34% of Burkitt lymphomas and not in DLBCLs. We show experimentally that ID3 mutations promote cell cycle progression and proliferation. Our work thus elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a new tumor suppressor gene.

2013-07-01 | GSE48435 | GEO